Together, these results suggested that CCL2-CCR4 signaling played an essential role in the local invasion and metastasis of HNSCC, and CCR4 might serve as a potential therapeutic molecular target by inhibiting tumor invasion metastasis [26]. The gene discussed is CCL2; the disease is neoplasm.